ArticleBiochemical Hepatic Changes in Chronic Hepatitis C Patients Induced by Sofosbuvir and Daclatasvir with or without Ribavirin Regimens
ArticleBiochemical Hepatic Changes in Chronic Hepatitis C Patients Induced by Sofosbuvir and Daclatasvir with or without Ribavirin Regimens
ArticleCorrelation of Serum Hepatitis C Viral Load and Immunobiochemical biomarkers in Combined Therapy Treated Patients
ArticleCorrelation of Serum Hepatitis C Viral Load and Immunobiochemical biomarkers in Combined Therapy Treated Patients
ArticleImmunological and biochemical parameters in patients with hepatitis C virus nephropathy before and after direct hepatitis C virus antiviral agents
ArticleImmunological and biochemical parameters in patients with hepatitis C virus nephropathy before and after direct hepatitis C virus antiviral agents
ArticleBiochemical and Molecular Alterations of Micro RNA 125b and Micro RNA 489-3p as diseases biomarkers in Hepatitis C Virus (HCV)
ArticleBiochemical and Molecular Alterations of Micro RNA 125b and Micro RNA 489-3p as diseases biomarkers in Hepatitis C Virus (HCV)
ArticleHepatitis C Virus Clearance with Sofosbuvir / Daclatasvir Regime Improves Oxidative Stress of Diabetic Status in HCV Patients by Regulating NF-κB / Nrf2 mRNA expression
ArticleHepatitis C Virus Clearance with Sofosbuvir / Daclatasvir Regime Improves Oxidative Stress of Diabetic Status in HCV Patients by Regulating NF-κB / Nrf2 mRNA expression
ArticleRESEARCH ARTICLE SERUM SYNDECAN-1 AND APOLIPOPROTEIN A1 IN PATIENTS WITH CHRONIC HCV INFECTION
ArticleRESEARCH ARTICLE SERUM SYNDECAN-1 AND APOLIPOPROTEIN A1 IN PATIENTS WITH CHRONIC HCV INFECTION